Search

We help you to accelerate drug discovery

Your partner in assay development, lab automation,
ultra-High Throughput Screening, High-Content Screening
and hit-to-lead biological profiling

Are you looking for lead candidate compounds for your target and do you want your drug discovery program to be more efficient, in terms of both time and cost?

Pivot Park Screening Centre is your optimal partner in early drug discovery

Projects are tailored to your requirements; We provide drug discovery services in the fields of biochemical, biophysical and cellular assay developmentlab automationultra-High Throughput Screening (uHTS, usually in 1536-well format), High-Content Screening and hit-to-lead biological profiling, in order to find novel leads for drug development. 

Furthermore all major read-out modalities are available in-house ensuring rapid generation of high-quality hits. As first CRO we integrated Mass Spectrometry (MALDI-TOF MS) into our uHTS system, thus providing you with the opportunity to run label-based and also label-free assays.

You can either bring your own small molecule library or use our 300K IP-free druglike compound library. Our fully automated robot system can handle small libraries, but also libraries from 2 mln. compounds per screen. As a matter of fact, over the past 10 years we have successfully completed more than 200 screening campaigns.

We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community.

In order to help you accelerate drug discovery for a healthier society. 

What makes Pivot Park Screening Centre unique?

Interested? Get in touch and we’ll help you accelerate your drug discovery.

Pivot Park Sreening Centre is located at Pivot Park in the Netherlands, because it focuses on pharmaceutical R&D. It is a particularly inspiring campus for open innovation in life sciences.

Early drug discovery

Discover what we can do for you

Discover our services

We offer amongst others assay development, hit identification, triaging as well as hit-to-lead profiling services to help you succeed in the early stages of the drug discovery process.

 

Discover our infrastructure

Pivot Park Screening Centre not only is equipped with advanced robotic systems but also ultra High Throughput Screening (uHTS), Mass Spectrometry and other lab automation services to accelerate your drug discovery.

Discover our projects

We work together with our customers and partners on the bases of open communication and trust. 

 

 

 

 

Discover Funding options

Funds available to promote the discovery of new medicines via assay development or ultra-High Throughput screening. 




Some facts & figures about Pivot Park Screening Centre

Compounds screened
0 mil.
Data points in 2022
0 mil.
Screens per year
0
Assays per year
0
Hit-to-lead programs finalized
0

Blog, News, Events & Stories

Cost Effective Screening in 384- and 1536 well plates
PPSC

Cost Effective Screening in 384 and 1536 well plates

Discover the advantages of utilizing both 384 and 1536 well plates in high-throughput screening (HTS). Learn how enhanced flexibility, cost-effectiveness, and adaptability can optimize your research efforts. Partner with us for streamlined data management and a competitive edge in drug discovery.

Read More »
Discovery US 2024 in Boston, November 7-8
Events

Discovery US 2024 in Boston, November 7-8

Join us at Discovery US and network with us and over 250 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimization.

Read More »
Five reasons for a startup to outsource a screen at PPSC

Are you a startup?

Read all about the 5 reasons to outsource a screen at PPSC

Is you assay amendable to uHTS? Seven aspects to consider

7 aspects to assess

Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…

What our clients say

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Join us on Linkedin